170 related articles for article (PubMed ID: 38454442)
61. Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway.
Yi X; Lou L; Wang J; Xiong J; Zhou S
Cancer Chemother Pharmacol; 2021 May; 87(5):647-656. PubMed ID: 33544209
[TBL] [Abstract][Full Text] [Related]
62. Exosomal miR-106a-5p accelerates the progression of nasopharyngeal carcinoma through FBXW7-mediated TRIM24 degradation.
Li CW; Zheng J; Deng GQ; Zhang YG; Du Y; Jiang HY
Cancer Sci; 2022 May; 113(5):1652-1668. PubMed ID: 35293097
[TBL] [Abstract][Full Text] [Related]
63. Circular RNA circ-BNC2 (hsa_circ_0008732) inhibits the progression of ovarian cancer through microRNA-223-3p/ FBXW7 axis.
Liu T; Yuan L; Zou X
J Ovarian Res; 2022 Aug; 15(1):95. PubMed ID: 35965327
[TBL] [Abstract][Full Text] [Related]
64. MicroRNA-92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7.
Yang W; Dou C; Wang Y; Jia Y; Li C; Zheng X; Tu K
Oncol Rep; 2015 Nov; 34(5):2576-84. PubMed ID: 26323375
[TBL] [Abstract][Full Text] [Related]
65. ANXA2 as a novel substrate of FBXW7 promoting esophageal squamous cell carcinoma via ERK phosphorylation.
Li Z; Pan Y; Yao J; Gao Y; Qian Y; Zheng M; Ma S
Biochem Biophys Res Commun; 2023 Mar; 649():93-100. PubMed ID: 36758484
[TBL] [Abstract][Full Text] [Related]
66. miR‑27a promotes human breast cancer cell migration by inducing EMT in a FBXW7‑dependent manner.
Jiang G; Shi W; Fang H; Zhang X
Mol Med Rep; 2018 Dec; 18(6):5417-5426. PubMed ID: 30365154
[TBL] [Abstract][Full Text] [Related]
67. SCF(FBXW7)-mediated degradation of p53 promotes cell recovery after UV-induced DNA damage.
Galindo-Moreno M; Giráldez S; Limón-Mortés MC; Belmonte-Fernández A; Reed SI; Sáez C; Japón MÁ; Tortolero M; Romero F
FASEB J; 2019 Oct; 33(10):11420-11430. PubMed ID: 31337255
[TBL] [Abstract][Full Text] [Related]
68. Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis.
Wang J; Wang H; Peters M; Ding N; Ribback S; Utpatel K; Cigliano A; Dombrowski F; Xu M; Chen X; Song X; Che L; Evert M; Cossu A; Gordan J; Zeng Y; Chen X; Calvisi DF
J Hepatol; 2019 Oct; 71(4):742-752. PubMed ID: 31195063
[TBL] [Abstract][Full Text] [Related]
69. LncRNA TTN-AS1 acts as sponge for miR-15b-5p to regulate FBXW7 expression in ovarian cancer.
Miao S; Wang J; Xuan L; Liu X
Biofactors; 2020 Jul; 46(4):600-607. PubMed ID: 32049388
[TBL] [Abstract][Full Text] [Related]
70. Loss of Fbxw7 triggers mammary tumorigenesis associated with E2F/c-Myc activation and Trp53 mutation.
Meyer AE; Furumo Q; Stelloh C; Minella AC; Rao S
Neoplasia; 2020 Nov; 22(11):644-658. PubMed ID: 33070870
[TBL] [Abstract][Full Text] [Related]
71. FAM83D associates with high tumor recurrence after liver transplantation involving expansion of CD44+ carcinoma stem cells.
Lin B; Chen T; Zhang Q; Lu X; Zheng Z; Ding J; Liu J; Yang Z; Geng L; Wu L; Zhou L; Zheng S
Oncotarget; 2016 Nov; 7(47):77495-77507. PubMed ID: 27769048
[TBL] [Abstract][Full Text] [Related]
72. Reduced expression of ubiquitin ligase FBXW7 mRNA is associated with poor prognosis in breast cancer patients.
Ibusuki M; Yamamoto Y; Shinriki S; Ando Y; Iwase H
Cancer Sci; 2011 Feb; 102(2):439-45. PubMed ID: 21134077
[TBL] [Abstract][Full Text] [Related]
73. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
[TBL] [Abstract][Full Text] [Related]
74. Gain of circBRAF Represses Glioma Progression by Regulating miR-1290/FBXW7 Axis.
Zhang J; Chen Z; Liu X; Yang C; Xie D
Neurochem Res; 2021 May; 46(5):1203-1213. PubMed ID: 33650075
[TBL] [Abstract][Full Text] [Related]
75. E3 ligase FBXW7 restricts M2-like tumor-associated macrophage polarization by targeting c-Myc.
Zhong L; Zhang Y; Li M; Song Y; Liu D; Yang X; Yang D; Qu H; Lai L; Wang Q; Chen Z
Aging (Albany NY); 2020 Dec; 12(23):24394-24423. PubMed ID: 33260160
[TBL] [Abstract][Full Text] [Related]
76. FBXW7 negatively regulates ENO1 expression and function in colorectal cancer.
Zhan P; Wang Y; Zhao S; Liu C; Wang Y; Wen M; Mao JH; Wei G; Zhang P
Lab Invest; 2015 Sep; 95(9):995-1004. PubMed ID: 26097998
[TBL] [Abstract][Full Text] [Related]
77. FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression.
Mao JH; Kim IJ; Wu D; Climent J; Kang HC; DelRosario R; Balmain A
Science; 2008 Sep; 321(5895):1499-502. PubMed ID: 18787170
[TBL] [Abstract][Full Text] [Related]
78. Distinct Interactions of EBP1 Isoforms with FBXW7 Elicits Different Functions in Cancer.
Wang Y; Zhang P; Wang Y; Zhan P; Liu C; Mao JH; Wei G
Cancer Res; 2017 Apr; 77(8):1983-1996. PubMed ID: 28209614
[TBL] [Abstract][Full Text] [Related]
79. FBP1 enhances the radiosensitivity by suppressing glycolysis via the FBXW7/mTOR axis in nasopharyngeal carcinoma cells.
Zhang P; Shao Y; Quan F; Liu L; Yang J
Life Sci; 2021 Oct; 283():119840. PubMed ID: 34298040
[TBL] [Abstract][Full Text] [Related]
80. miR-25 promotes metastasis via targeting FBXW7 in esophageal squamous cell carcinoma.
Hua Y; Zhao K; Tao G; Dai C; Su Y
Oncol Rep; 2017 Nov; 38(5):3030-3038. PubMed ID: 29048664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
